IMPACT OF TREATMENT SWITCH ON CLINICAL OUTCOMES IN CROHN’S DISEASE PATIENTS IN THE UNITED STATES AND 5 EUROPEAN COUNTRIES (FRANCE, GERMANY, ITALY, SPAIN, UK)
Myrlene Sanon 1
Jim Kershaw 2
Sumesh Kachroo 3
Sophie Barlow 3
Timothy Hoops 3
Dominik Naessens 4
Cynthia Willey 5
1 Janssen Global Services, Horsham, United States
2 Adelphi Real World, Cheshire, United Kingdom
3 Janssen Scientific Affairs, Horsham, United States
4 Janssen Pharmaceutica NV, Beerse, Belgium
5 College of Pharmacy, University of Rhode Island, Kingston, United States
Conference
UEG Week Vienna 2022
Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]